Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / NVIV - InVivo is up after peer-reviewed publication of study on spinal cord injury


NVIV - InVivo is up after peer-reviewed publication of study on spinal cord injury

InVivo Therapeutics ([[NVIV]] +5.4%) is trading higher today in above-average volume after the company announced the publication of a peer-reviewed manuscript describing the complete six-month primary endpoint results from its single-arm INSPIRE 1.0 study.The publication in the Journal of Neurosurgery: Spine includes complete six-month primary endpoint results from the study that evaluated its Neuro-Spinal Scaffold in patients with complete thoracic AIS A spinal cord injury. The results were first announced in 2018.The company has officially closed the trial and the enrollment is underway for a second pivotal clinical study of the Neuro-Spinal Scaffold™ in patients with acute SCI (INSPIRE 2.0).The 12-month data of the study were disclosed in April 2019.

For further details see:

InVivo is up after peer-reviewed publication of study on spinal cord injury
Stock Information

Company Name: InVivo Therapeutics Holdings Corp.
Stock Symbol: NVIV
Market: NASDAQ

Menu

NVIV NVIV Quote NVIV Short NVIV News NVIV Articles NVIV Message Board
Get NVIV Alerts

News, Short Squeeze, Breakout and More Instantly...